Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Patel PC, Fishbane N, Watanabe A, Rolsma S, Kirkpatrick CMJ, Landersdorfer CB, Winokur P. An G, et al. Among authors: landersdorfer cb. J Antimicrob Chemother. 2023 Jun 1;78(6):1460-1470. doi: 10.1093/jac/dkad106. J Antimicrob Chemother. 2023. PMID: 37071586 Free PMC article.
Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trial.
Kong FYS, Unemo M, Lim SH, Latch N, Williamson DA, Roberts JA, Wallis SC, Parker SL, Landersdorfer CB, Yap T, Fairley CK, Chow EPF, Lewis DA, Hammoud MA, Hocking JS. Kong FYS, et al. Among authors: landersdorfer cb. BMJ Open. 2022 Nov 11;12(11):e064782. doi: 10.1136/bmjopen-2022-064782. BMJ Open. 2022. PMID: 36368750 Free PMC article. Clinical Trial.
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses".
Antachopoulos C, Geladari A, Landersdorfer CB, Volakli E, Ilia S, Gikas E, Gika H, Sdougka M, Nation RL, Roilides E. Antachopoulos C, et al. Among authors: landersdorfer cb. Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0168522. doi: 10.1128/aac.01685-22. Epub 2023 Jan 19. Antimicrob Agents Chemother. 2023. PMID: 36656004 Free PMC article. No abstract available.
Construction of a Synthetic Colostrum Substitute and Its Protection of Intestinal Cells against Inflammation in an In Vitro Model of Necrotizing Enterocolitis.
Binte Abu Bakar SY, Salim M, Clulow AJ, Seibt S, Landersdorfer CB, Geddes DT, Nicholas KR, Boyd BJ. Binte Abu Bakar SY, et al. Among authors: landersdorfer cb. ACS Appl Mater Interfaces. 2023 Aug 2;15(30):35847-35859. doi: 10.1021/acsami.3c05012. Epub 2023 Jul 22. ACS Appl Mater Interfaces. 2023. PMID: 37480336
Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.
Krueger WA, Bulitta J, Kinzig-Schippers M, Landersdorfer C, Holzgrabe U, Naber KG, Drusano GL, Sörgel F. Krueger WA, et al. Antimicrob Agents Chemother. 2005 May;49(5):1881-9. doi: 10.1128/AAC.49.5.1881-1889.2005. Antimicrob Agents Chemother. 2005. PMID: 15855510 Free PMC article. Clinical Trial.
139 results